Global Market Insights into Cytokine Release Syndrome Treatment
Cytokine Release Syndrome (CRS) is a systemic inflammatory response that occurs when a large number of immune cells are activated and release pro-inflammatory cytokines into the bloodstream. CRS is most commonly seen as a side effect of certain immunotherapies, including chimeric antigen receptor T-cell (CAR-T) therapies and monoclonal antibodies. While CRS is a potentially...
0 Shares
45 Views
0 Reviews